Document Detail


How to approach hypercalcaemia.
MedLine Citation:
PMID:  23760705     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The management of patients with hypercalcaemia should be informed by the patient's symptoms and signs, by the degree of elevation of calcium, by the underlying mechanism by which calcium has been elevated and by the disease process underlying the presentation. Regardless of diagnosis, all significantly hypercalcaemic patients should be rendered euvolaemic before any further and more specific treatment is considered. Highly symptomatic patients and those with a calcium level of > 3.5 mmol represent a medical emergency that requires inpatient treatment.
Authors:
Rachel Crowley; Neil Gittoes
Related Documents :
20223415 - Comparison of geometries for in vivo measurements of actinides in the skull.
18267485 - End-to-end color printer calibration by total least squares regression.
17002405 - Measurement of soluble solids contents and ph in orange juice using chemometrics and vi...
19489615 - Determination of protein content of auricularia auricula using near infrared spectrosco...
11798095 - A long-term validation of the modernised dc-arc-oes solid-sample method.
17178655 - Effects of conflict alerting system reliability and task difficulty on pilots' conflict...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical medicine (London, England)     Volume:  13     ISSN:  1470-2118     ISO Abbreviation:  Clin Med     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-06-13     Completed Date:  2013-08-23     Revised Date:  2013-11-19    
Medline Journal Info:
Nlm Unique ID:  101092853     Medline TA:  Clin Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  287-90     Citation Subset:  IM    
Affiliation:
University Hospitals Birmingham NHS Foundation Trust, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / blood
Calcium / blood*
Diagnosis, Differential
Diphosphonates / blood*
Hospitalization*
Humans
Hypercalcemia / blood,  diagnosis*,  etiology,  therapy
Hyperparathyroidism, Primary / complications
Neoplasms / complications
Parathyroid Hormone / blood*
Parathyroid Hormone-Related Protein / blood
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Diphosphonates; 0/Parathyroid Hormone; 0/Parathyroid Hormone-Related Protein; 7440-70-2/Calcium
Comments/Corrections
Comment In:
Clin Med. 2013 Oct;13(5):525   [PMID:  24115719 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Monogenic diabetes: old and new approaches to diagnosis.
Next Document:  Effects of antioxidants and MAPK inhibitors on cell death and reactive oxygen species levels in H2O2...